Literature DB >> 19420485

Thermosensitive liposomes entrapping iron oxide nanoparticles for controllable drug release.

Lin-Ai Tai1, Pi-Ju Tsai, Yu-Chao Wang, Yu-Jing Wang, Leu-Wei Lo, Chung-Shi Yang.   

Abstract

Iron oxide nanoparticles can serve as a heating source upon alternative magnetic field (AMF) exposure. Iron oxide nanoparticles can be mixed with thermosensitive nanovehicles for hyperthermia-induced drug release, yet such a design and mechanism may not be suitable for controllable drug release applications in which the tissues are susceptible to environmental temperature change such as brain tissue. In the present study, iron oxide nanoparticles were entrapped inside of thermosensitive liposomes for AMF-induced drug release while the environmental temperature was maintained at a constant level. Carboxyfluorescein was co-entrapped with the iron oxide nanoparticles in the liposomes as a model compound for monitoring drug release and environmental temperature was maintained with a water circulator jacket. These experiments have been successfully performed in solution, in phantom and in anesthetized animals. Furthermore, the thermosensitive liposomes were administered into rat forearm skeletal muscle, and the release of carboxylfluorescein triggered by the external alternative magnetic field was monitored by an implanted microdialysis perfusion probe with an on-line laser-induced fluorescence detector. In the future such a device could be applied to simultaneous magnetic resonance imaging and non-invasive drug release in temperature-sensitive applications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19420485     DOI: 10.1088/0957-4484/20/13/135101

Source DB:  PubMed          Journal:  Nanotechnology        ISSN: 0957-4484            Impact factor:   3.874


  31 in total

1.  Nanotechnology for energy-based cancer therapies.

Authors:  Kyle Gilstrap; Xiaoxiao Hu; Xiongbin Lu; Xiaoming He
Journal:  Am J Cancer Res       Date:  2011-03-11       Impact factor: 6.166

Review 2.  Hybrid nanoparticles for detection and treatment of cancer.

Authors:  Michael J Sailor; Ji-Ho Park
Journal:  Adv Mater       Date:  2012-05-21       Impact factor: 30.849

Review 3.  Hybrid lipid-nanoparticle complexes for biomedical applications.

Authors:  Kevin M Vargas; Young-Seok Shon
Journal:  J Mater Chem B       Date:  2019-01-03       Impact factor: 6.331

Review 4.  Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications.

Authors:  Seyed Mohammadali Dadfar; Karolin Roemhild; Natascha I Drude; Saskia von Stillfried; Ruth Knüchel; Fabian Kiessling; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2019-01-11       Impact factor: 15.470

Review 5.  Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery.

Authors:  Challa S S R Kumar; Faruq Mohammad
Journal:  Adv Drug Deliv Rev       Date:  2011-04-05       Impact factor: 15.470

6.  Release, partitioning, and conjugation stability of doxorubicin in polymer micelles determined by mechanistic modeling.

Authors:  Andrei Ponta; Kyle D Fugit; Bradley D Anderson; Younsoo Bae
Journal:  Pharm Res       Date:  2014-11-19       Impact factor: 4.200

7.  Cooperative nanoparticles for tumor detection and photothermally triggered drug delivery.

Authors:  Ji-Ho Park; Geoffrey von Maltzahn; Luvena L Ong; Andrea Centrone; T Alan Hatton; Erkki Ruoslahti; Sangeeta N Bhatia; Michael J Sailor
Journal:  Adv Mater       Date:  2010-02-23       Impact factor: 30.849

Review 8.  Materials to clinical devices: technologies for remotely triggered drug delivery.

Authors:  Brian P Timko; Daniel S Kohane
Journal:  Clin Ther       Date:  2012-11       Impact factor: 3.393

Review 9.  Intelligent design of multifunctional lipid-coated nanoparticle platforms for cancer therapy.

Authors:  Srinivas Ramishetti; Leaf Huang
Journal:  Ther Deliv       Date:  2012-12

10.  Remotely triggered cisplatin release from carbon nanocapsules by radiofrequency fields.

Authors:  Mustafa Raoof; Brandon T Cisneros; Adem Guven; Sophia Phounsavath; Stuart J Corr; Lon J Wilson; Steven A Curley
Journal:  Biomaterials       Date:  2012-12-08       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.